March Home Sales Miss: What It Means for Housing Stocks
U.S. existing home sales fell 3.6% in March—far worse than the 0.7% consensus estimate. What the miss means for homebuilder stocks, REITs, and mortgage markets.
U.S. existing home sales fell 3.6% in March—far worse than the 0.7% consensus estimate. What the miss means for homebuilder stocks, REITs, and mortgage markets.
From protein folding to clinical trials, AI is transforming drug discovery. Novo Nordisk’s OpenAI deal is the latest signal for pharma investors.
From frozen IPOs to widening credit spreads, the US-China 145% tariff war is reshaping capital markets in ways not seen since the financial crisis.
Oracle and Bloom Energy are expanding their strategic partnership to deploy 2.8 GW of on-site fuel cell power for AI data centers, sending Oracle stock up 12.7%.
The Trump administration’s 100% pharmaceutical tariff threat is testing drug stock valuations, global supply chains, and corporate bond markets.
OpenAI’s private market valuation has ballooned to $852 billion, but some of its own backers are questioning the math as the company shifts strategic focus.
Amazon is in advanced talks to acquire Globalstar, a move that could reshape the satellite internet race against SpaceX Starlink and trigger a new wave of space sector M&A.
CATL, the world’s largest EV battery maker, is eyeing a $5B Hong Kong share sale. Here’s what the deal signals for global capital markets and Chinese company listings.
United Airlines CEO Scott Kirby raised a potential merger with American Airlines during a Trump White House meeting, reviving the biggest airline M&A question in a decade.
ASML reports Q1 2026 earnings this week. As the sole maker of EUV machines, its order book is the best indicator of where the AI chip supercycle is headed.